Last update 31 Oct 2025

IMD303

Overview

Basic Info

Drug Type
Probody
Synonyms
IMD-303, IMD303
Target
CTLA4
Action
inhibitors
Mechanism
CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumorNeoplasms
Inactive Indication-
Originator Organization
Shanghai Affinity Biopharmaceutical Co., Ltd.Shanghai Affinity Biopharmaceutical Co., Ltd.
Active Organization
Affinity (Chengdu) Pharmaceutical Co., Ltd.Shanghai Affinity Biopharmaceutical Co., Ltd.Shanghai Affinity Biopharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with IMD303
CTR20254207
/ Not yet recruitingPhase 1
一项开放、国际多中心的 I 期临床试验，旨在评估注射用IMD303对晚期恶性实体肿瘤患者的安全性、耐受性和初步有效性
[Translation] An open-label, international, multicenter Phase I clinical trial designed to evaluate the safety, tolerability, and preliminary efficacy of IMD303 for injection in patients with advanced solid tumors
100 Clinical Results associated with IMD303
Login to view more data
100 Translational Medicine associated with IMD303
Login to view more data
100 Patents (Medical) associated with IMD303
Login to view more data
100 Deals associated with IMD303
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Affinity (Chengdu) Pharmaceutical Co., Ltd.
24 Oct 2025
Solid tumorIND Application-
Shanghai Affinity Biopharmaceutical Co., Ltd.Shanghai Affinity Biopharmaceutical Co., Ltd.
-
NeoplasmsPreclinical
China
Shanghai Affinity Biopharmaceutical Co., Ltd.Shanghai Affinity Biopharmaceutical Co., Ltd.
29 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free